Waycross Partners’s Nutrien NTR Stock Holding History

Waycross Partners’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$1.5M	–	88
2021 Q4	$1.5M	Hold	20,000	–	–	0.86%	40
2021 Q3	$1.3M	Hold	20,000	–	–	0.82%	45
2021 Q2	$1.21M	Hold	20,000	–	–	0.64%	45
2021 Q1	$1.08M	Buy	+20,000	New	+$1.09M	0.6%	51

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Waycross Partners's NTR Position: Q1 2022 in Review

Waycross Partners sold out of Nutrien (NTR) in Q1 2022, closing a stake of 20,000 shares — an estimated $1.5M sold.

Waycross Partners first reported a position in NTR in Q1 2021 and held it in 4 quarters. The position peaked at $1.5M in Q4 2021. 756 funds tracked by Wall St. Rank hold NTR as of Q1 2022.

Waycross Partners reported no remaining Nutrien position as of Q1 2022 after selling out during the quarter.
Waycross Partners sold 20,000 Nutrien shares in Q1 2022, an estimated $1.5M.
Waycross Partners first reported a position in Nutrien in Q1 2021 and held it in 4 quarters.
Waycross Partners's Nutrien position peaked at $1.5M in Q4 2021.
756 funds tracked by Wall St. Rank held Nutrien as of Q1 2022.

Based on Waycross Partners's 13F filing for Q1 2022, filed 29 Apr 2022.